Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

XLCI vs XLVI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

XLVI Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

XLVI Overall Winner 6-Pillar Tally: XLCI 0 – 0 XLVI (6 Tie) Matrix Metrics: XLCI 0 – 3 XLVI

As of Nov 16, 2026, The Health Care Select Sector SPDR Premium Income Fund (XLVI) is the stronger overall head-to-head candidate over The Communication Services Select Sector SPDR Premium Income Fund (XLCI) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XLCI carries a Unified Composite Score of 40.6/100 (SELL) at $22.50 (N/M Forward P/E, N/A operating margin), whereas XLVI carries 51.1/100 (HOLD) at $27.33 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: XLCI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.2); meanwhile XLVI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 56.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About XLCI vs XLVI
XLCI NYSE Arca
The Communication Services Select Sector SPDR Premium Income Fund
Institutional Equity
$22.50
-1.59% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.60β · 21% Vol
Unified Composite Score
40.6 / 100 SELL
Tech 28.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.3%) with fading momentum, RSI 48
RSI-14: 48.2 · SMA20: $22.30 · SMA50: $23.13
XLVI NYSE Arca Head-to-Head Winner
The Health Care Select Sector SPDR Premium Income Fund
Institutional Equity
$27.33
-0.47% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.20β · 9% Vol
Unified Composite Score
51.1 / 100 HOLD
Tech 42.0 Fund 50.0 Flow 50.0 Mom 41.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 56
RSI-14: 56.4 · SMA20: $27.28 · SMA50: $26.65

6-Pillar Scorecard Institutional Category Breakdown (XLCI 0 – 0 XLVI)

Columns: Metric · XLCI · XLVI
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: XLCI (0) vs XLVI (3)
Institutional Metric XLCI XLVI Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
30% ($21–$26) 89% ($24–$28) Stronger Trend XLVI
Beta / 30D Volatility
Risk Regime
0.60β · 21% Vol 0.20β · 9% Vol Lower Realized Risk XLVI
Unified Institutional Score
Composite Signal
40.6 / 100 (SELL) 51.1 / 100 (HOLD) Higher Composite XLVI
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon XLVI +4.8 pp
XLCI: -3.28% · XLVI: +1.52%
3M Horizon XLVI +4.44 pp
XLCI: -4.04% · XLVI: +0.4%
6M Horizon XLVI +19.9 pp
XLCI: -9.74% · XLVI: +10.16%
1Y Horizon XLVI +11.85 pp
XLCI: -7.93% · XLVI: +3.92%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XLCI vs XLVI. Trailing 12-month operating profitability (XLCI N/A vs XLVI N/A) and valuation multiples (XLCI N/M vs XLVI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

XLCI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
XLVI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
XLCI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XLCI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
XLVI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XLVI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
XLCI Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
XLVI Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ XLCI vs XLVI Key Questions & Quantitative Answers

As of Nov 16, 2026, The Health Care Select Sector SPDR Premium Income Fund (XLVI) is the stronger overall head-to-head candidate over The Communication Services Select Sector SPDR Premium Income Fund (XLCI) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). XLCI carries a Unified Composite Score of 40.6/100 (SELL) at $22.50 (N/M Forward P/E, N/A operating margin), whereas XLVI carries 51.1/100 (HOLD) at $27.33 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: XLCI is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.2); meanwhile XLVI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 56.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

XLCI and XLVI split Growth & Scale metrics: XLCI posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with XLVI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, XLCI generates N/A in USD-normalized revenue versus N/A for XLVI. In operating R&D and SG&A reinvestment, XLCI deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for XLVI.

XLCI and XLVI trade at balanced relative valuation multiples. XLCI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas XLVI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against XLCI (N/A ROE) versus XLVI (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, XLCI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.60β · 21% Vol realized risk). By comparison, XLVI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.20β · 9% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

The Communication Services Select Sector SPDR Premium Income Fund (XLCI) Research Suite

The Health Care Select Sector SPDR Premium Income Fund (XLVI) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.